Galectin-1 expression by regulatory T cells is required for sustained modulation of chronic colitis in regulatory T cell-based therapy

被引:0
|
作者
Fernandez Perez, Raquel
Alberquilla, Omaira
Sanchez, Rebeca
Martin, Miguel A.
Bueren, Juan A.
Garin, Marina I.
机构
[1] Ctr Invest Energet Medioambient & Tecnol CIEMAT, Div Hematopoiet Innovat Therapies, Madrid, Spain
[2] Ctr Invest Biomed Red Enfermedades Raras CIBER ER, Madrid, Spain
[3] Inst Invest Sanitaria Fdn Jimenez Diaz IIS FJD, Adv Therapies Mixed Unit, Madrid, Spain
关键词
Adaptive immunity; autoimmunity; cell based therapies; immune regulation and therapy; inflammatory bowel disease; regulatory cells;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
P-0601
引用
收藏
页码:390 / 390
页数:1
相关论文
共 50 条
  • [41] OX40 is required for regulatory T cell-mediated control of colitis
    Griseri, Thibault
    Asquith, Mark
    Thompson, Claire
    Powrie, Fiona
    JOURNAL OF EXPERIMENTAL MEDICINE, 2010, 207 (04): : 699 - 709
  • [42] MESENCHYMAL STEM CELLS INDUCED IN VITRO GENERATION OF REGULATORY T-CELLS: A CELL-BASED THERAPY TO PROMOTE TRANSPLANTATION TOLERANCE
    Dave, Shruti D.
    Vanikar, Aruna V.
    Trivedi, Hargovind L.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 34 - 34
  • [43] Recombinant galectin-1 prevents experimental colitis in mice via T cell apoptosis.
    Santucci, L
    Fiorucci, S
    Cammilleri, F
    Mencarelli, A
    Federici, B
    GASTROENTEROLOGY, 2000, 118 (04) : A577 - A577
  • [44] Improving regulatory T cell-based therapy: insights into post-translational modification regulation
    Wang, Aiting
    Wang, Yanwen
    Liang, Rui
    Li, Bin
    Pan, Fan
    JOURNAL OF GENETICS AND GENOMICS, 2025, 52 (02): : 145 - 156
  • [45] Recruitment of high avidity antigen specific T cells with T regulatory cell modulation
    Jaffee, E
    JOURNAL OF IMMUNOTHERAPY, 2005, 28 (06) : 649 - 649
  • [46] Cell therapy with human T regulatory type 1 cells in allogeneic transplantations
    Bacchetta, Rosa
    Gregori, Silvia
    Barbarelle, Lucarelli
    Roncarolo, Maria Grazia
    IMMUNOTHERAPY, 2011, 3 (04) : 27 - 27
  • [47] Regulatory T cell-based immunotherapies in experimental autoimmune myasthenia gravis
    Souroujon, Miriam C.
    Aricha, Revital
    Feferman, Tali
    Mizrachi, Keren
    Reuveni, Debby
    Fuchs, Sara
    MYASTHENIA GRAVIS AND RELATED DISORDERS I, 2012, 1274 : 120 - 126
  • [48] Galectin-1 reduction and changes in T regulatory cells may play crucial roles in patients with unexplained recurrent spontaneous abortion
    Wu, Minjun
    Liu, Ping
    Cheng, Licun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (02): : 1973 - 1978
  • [49] IMPROVING DENDRITIC CELL-BASED IMMUNOTHERAPY BY MODULATING IMMUNE SUPPRESSIVE REGULATORY T CELLS IN MESOTHELIOMA
    Cornelissen, Robin
    Hegmans, Joost
    Veltman, Joris
    Heuvers, Marlies
    Lambers, Margaretha
    Muskens, Femke
    Lambrecht, Bart
    Hendriks, Rudi
    Hoogsteden, Henk
    Aerts, Joachim G.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S485 - S486
  • [50] Regulatory T Cells in Atherosclerosis: Is Adoptive Cell Therapy Possible?
    Churov, Alexey V.
    Chegodaev, Yegor S.
    Khotina, Victoria A.
    Ofitserov, Vladimir P.
    Orekhov, Alexander N.
    LIFE-BASEL, 2023, 13 (09):